sodium salicylate has been researched along with 6-ketoprostaglandin f1 alpha in 4 studies
Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (6-ketoprostaglandin f1 alpha) | Trials (6-ketoprostaglandin f1 alpha) | Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha) |
---|---|---|---|---|---|
2,031 | 50 | 171 | 4,832 | 294 | 150 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kasdon, E; Marrone, G; Rowe, PH; Silen, W; Starlinger, MJ | 1 |
Dahl, ML; Uotila, P | 1 |
Choi, DJ; Jung, TT; Park, YS; Rhee, CK | 1 |
Giuliano, F; Mitchell, JA; Warner, TD | 1 |
4 other study(ies) available for sodium salicylate and 6-ketoprostaglandin f1 alpha
Article | Year |
---|---|
Effect of simulated systemic administration of aspirin, salicylate, and indomethacin on amphibian gastric mucosa.
Topics: 16,16-Dimethylprostaglandin E2; 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Dinoprost; Dinoprostone; Electrophysiology; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Indomethacin; Metiamide; Prostaglandins; Prostaglandins E; Prostaglandins F; Rana catesbeiana; Sodium Salicylate; Time Factors | 1986 |
Sodium salicylate does not prevent the inhibitory effect of indomethacin on thromboxane formation in human blood ex vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Blood Coagulation; Humans; Indomethacin; Male; Radioimmunoassay; Sodium Salicylate; Thromboxane B2; Thromboxanes | 1985 |
Effect of corticosteroid treatment on salicylate ototoxicity.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Chinchilla; Dexamethasone; Evoked Potentials, Auditory, Brain Stem; Hearing Disorders; Leukotrienes; Perilymph; Sensory Thresholds; Sodium Salicylate | 1994 |
Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blotting, Western; Cardiovascular System; Cholinesterase Inhibitors; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Drug Interactions; Enzyme Induction; Isoenzymes; Isoflurophate; Lipopolysaccharides; Male; Nitrates; Nitrites; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Wistar; Sodium Salicylate | 2001 |